Pharmacologic inhibition of lysine-specific demethylase 1 as a therapeutic and immune-sensitization strategy in pediatric high-grade glioma

免疫系统 癌症研究 细胞毒性 基因签名 免疫疗法 胶质瘤 生物 细胞毒性T细胞 自然杀伤细胞 CD8型 免疫学 体外 基因表达 基因 生物化学
作者
Cavan P. Bailey,Mary Figueroa,Achintyan Gangadharan,Yanwen Yang,Megan M. Romero,Bridget Kennis,Sridevi Yadavilli,Verlene Henry,Tiara L. Collier,Michelle Monje,Dean A. Lee,Linghua Wang,Javad Nazarian,Vidya Gopalakrishnan,Wafik Zaky,Oren J. Becher,Joya Chandra
出处
期刊:Neuro-oncology [Oxford University Press]
卷期号:22 (9): 1302-1314 被引量:50
标识
DOI:10.1093/neuonc/noaa058
摘要

Abstract Background Diffuse midline gliomas (DMG), including brainstem diffuse intrinsic pontine glioma (DIPG), are incurable pediatric high-grade gliomas (pHGG). Mutations in the H3 histone tail (H3.1/3.3-K27M) are a feature of DIPG, rendering them therapeutically sensitive to small-molecule inhibition of chromatin modifiers. Pharmacological inhibition of lysine-specific demethylase 1 (LSD1) is clinically relevant but has not been carefully investigated in pHGG or DIPG. Methods Patient-derived DIPG cell lines, orthotopic mouse models, and pHGG datasets were used to evaluate effects of LSD1 inhibitors on cytotoxicity and immune gene expression. Immune cell cytotoxicity was assessed in DIPG cells pretreated with LSD1 inhibitors, and informatics platforms were used to determine immune infiltration of pHGG. Results Selective cytotoxicity and an immunogenic gene signature were established in DIPG cell lines using clinically relevant LSD1 inhibitors. Pediatric HGG patient sequencing data demonstrated survival benefit of this LSD1-dependent gene signature. Pretreatment of DIPG with these inhibitors increased lysis by natural killer (NK) cells. Catalytic LSD1 inhibitors induced tumor regression and augmented NK cell infusion in vivo to reduce tumor burden. CIBERSORT analysis of patient data confirmed NK infiltration is beneficial to patient survival, while CD8 T cells are negatively prognostic. Catalytic LSD1 inhibitors are nonperturbing to NK cells, while scaffolding LSD1 inhibitors are toxic to NK cells and do not induce the gene signature in DIPG cells. Conclusions LSD1 inhibition using catalytic inhibitors is selectively cytotoxic and promotes an immune gene signature that increases NK cell killing in vitro and in vivo, representing a therapeutic opportunity for pHGG. Key Points 1. LSD1 inhibition using several clinically relevant compounds is selectively cytotoxic in DIPG and shows in vivo efficacy as a single agent. 2. An LSD1-controlled gene signature predicts survival in pHGG patients and is seen in neural tissue from LSD1 inhibitor–treated mice. 3. LSD1 inhibition enhances NK cell cytotoxicity against DIPG in vivo and in vitro with correlative genetic biomarkers.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Jiannuk完成签到,获得积分10
刚刚
gulu完成签到,获得积分20
刚刚
优雅的怀莲完成签到,获得积分10
刚刚
1秒前
小蘑材完成签到,获得积分10
1秒前
PsyQin完成签到,获得积分10
1秒前
六边形猪宝完成签到 ,获得积分10
1秒前
舒心橘子完成签到,获得积分10
1秒前
赤练仙子发布了新的文献求助10
2秒前
Puddingo完成签到,获得积分10
2秒前
野火哈机密完成签到,获得积分10
2秒前
xiaowan完成签到,获得积分10
2秒前
洛宁发布了新的文献求助10
2秒前
2秒前
柏朴完成签到,获得积分10
2秒前
敏感的花卷完成签到,获得积分10
3秒前
3秒前
牛iu发布了新的文献求助10
3秒前
nanchuangjiao完成签到,获得积分10
3秒前
nikola完成签到,获得积分20
3秒前
李健的应助被寒食采纳,获得10
3秒前
goodman完成签到,获得积分10
3秒前
yy完成签到,获得积分10
4秒前
发呆小天才儿完成签到 ,获得积分10
4秒前
4秒前
4秒前
yy完成签到,获得积分20
4秒前
宁恕完成签到,获得积分10
5秒前
FashionBoy的应助被躺赢的猴哥采纳,获得10
5秒前
超级小楠完成签到,获得积分10
6秒前
黑客帝国完成签到,获得积分10
6秒前
寒赤月完成签到,获得积分10
6秒前
科研通AI65的应助被吹球球8采纳,获得10
6秒前
传奇3的应助被么么采纳,获得10
6秒前
6秒前
iNk的应助被Wang采纳,获得10
6秒前
7秒前
lemon完成签到,获得积分10
7秒前
星空发布了新的文献求助10
8秒前
好好完成签到,获得积分10
8秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
Social Psychology in the Real World 600
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8180407
求助须知:如何正确求助?哪些是违规求助? 9570403
关于积分的说明 21811831
捐赠科研通 7776452
什么是DOI,文献DOI怎么找? 3433277
关于科研通互助平台的介绍 2557499
邀请新用户注册赠送积分活动 2479105